Claesen M - Search Results

1

1,3-dipalmitoylglycerol ester of chlorambucil as a lymphotropic, orally administrable antineoplastic agent.

Garzon-Aburbeh A, Poupaert JH, Claesen M, Dumont P, Atassi G. Garzon-Aburbeh A, et al. Among authors: claesen m. J Med Chem. 1983 Aug;26(8):1200-3. doi: 10.1021/jm00362a021. J Med Chem. 1983. PMID: 6876088

2

A lymphotropic prodrug of L-dopa: synthesis, pharmacological properties, and pharmacokinetic behavior of 1,3-dihexadecanoyl-2-[(S)-2-amino-3-(3,4-dihydroxyphenyl)prop anoyl] propane-1,2,3-triol.

Garzon-Aburbeh A, Poupaert JH, Claesen M, Dumont P. Garzon-Aburbeh A, et al. Among authors: claesen m. J Med Chem. 1986 May;29(5):687-91. doi: 10.1021/jm00155a018. J Med Chem. 1986. PMID: 3084786

3

Stereochemical aspects of the metabolism of 5-(4'-fluorophenyl)-5-phenylhydantoin in the rat.

Poupaert JH, Adline J, Claesen MH, De Laey P, Dumont PA. Poupaert JH, et al. Among authors: claesen mh. J Med Chem. 1979 Sep;22(9):1140-2. doi: 10.1021/jm00195a029. J Med Chem. 1979. PMID: 490562

4

Absolute configuration of the major metabolite of 5,5-diphenylhydantoin, 5-(4'-hydroxyphenyl)-5-phenylhydantoin.

Poupaert JH, Cavalier R, Claesen MH, Dumont PA. Poupaert JH, et al. Among authors: claesen mh. J Med Chem. 1975 Dec;18(12):1268-71. doi: 10.1021/jm00246a024. J Med Chem. 1975. PMID: 1195283

5

Search for 5-(2-hydroxyphenyl)-5-phenylhydantoin as a metabolite of phenytoin.

Poupaert JH, Moustafa M, Smeyers C, Adline J, Vandervorst D, Claesen M, Dumont P. Poupaert JH, et al. Among authors: claesen m. J Pharm Belg. 1982 Jan-Feb;37(1):47-52. J Pharm Belg. 1982. PMID: 7077512 No abstract available.

6

HPLC semi-preparative approach of the metabolites of phenytoin.

Poupaert JH, Garzon A, Moustafa M, Claesen M, Dumont P. Poupaert JH, et al. Among authors: claesen m. J Pharm Belg. 1980 Jul-Aug;35(4):320-2. J Pharm Belg. 1980. PMID: 7441482 No abstract available.

7

Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.

Claesen M, Moustafa MA, Adline J, Vandervorst D, Poupaert JH. Claesen M, et al. Drug Metab Dispos. 1982 Nov-Dec;10(6):667-71. Drug Metab Dispos. 1982. PMID: 6130920

8

Anticonvulsant potency of two deuterated analogues of phenytoin: "DPH-pd and DPH-d5".

Dumont P, Poupaert JH, De Laey P, Claesen M. Dumont P, et al. Among authors: claesen m. J Pharm Belg. 1981 Jan-Feb;36(1):21-6. J Pharm Belg. 1981. PMID: 7229901 No abstract available.

9

Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog.

Moustafa MA, Claesen M, Adline J, Vandervorst D, Poupaert JH. Moustafa MA, et al. Among authors: claesen m. Drug Metab Dispos. 1983 Nov-Dec;11(6):574-80. Drug Metab Dispos. 1983. PMID: 6140142

10

Syntheses and hydrolysis of basic and dibasic ampicillin esters tailored for intracellular accumulation.

Paternotte I, Fan HJ, Scrève P, Claesen M, Tulkens PM, Sonveaux E. Paternotte I, et al. Among authors: claesen m. Bioorg Med Chem. 2001 Feb;9(2):493-502. doi: 10.1016/s0968-0896(00)00255-8. Bioorg Med Chem. 2001. PMID: 11249141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters